Risk factors
UNITED Therapeutics (UTHR) risk factors
Item 1A of every UNITED Therapeutics Corp. 10-K on file, and what changed from one year to the next.
- 2026 10-K risk factors
32 risks, 2 new, 6 dropped, 10 reworded since the prior year. Drug-pricing pressure now includes the 2025 Part D redesign, Medicaid reductions, possible tariffs, and most-favored-nation pricing demands.
Filed Feb 25, 2026 - 2025 10-K risk factors
36 risks. Treprostinil therapies generate most revenue, making product sales, competition, reimbursement, and manufacturing central risks.
Filed Feb 26, 2025